SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $700,876,985 | +156.6% | 3,303,686 | +132.8% | 1.43% | +137.9% |
| Q2 2023 | $273,165,984 | +262.7% | 1,419,339 | +281.6% | 0.60% | +218.0% |
| Q1 2023 | $75,314,791 | +87.0% | 371,980 | +18.7% | 0.19% | +70.3% |
| Q4 2022 | $40,274,906 | +226.1% | 313,399 | +247.2% | 0.11% | +192.1% |
| Q3 2022 | $12,350,000 | -86.7% | 90,262 | -82.7% | 0.04% | -87.4% |
| Q2 2022 | $92,536,000 | +99.4% | 522,978 | +62.4% | 0.30% | +106.2% |
| Q1 2022 | $46,397,000 | +105.1% | 322,090 | +120.1% | 0.15% | +89.6% |
| Q4 2021 | $22,621,000 | -56.9% | 146,322 | -56.0% | 0.08% | -69.0% |
| Q2 2021 | $52,530,000 | +151.4% | 332,718 | +121.1% | 0.25% | +140.8% |
| Q1 2021 | $20,893,000 | +697.7% | 150,461 | +906.2% | 0.10% | +586.7% |
| Q4 2020 | $2,619,000 | – | 14,953 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |